MYD88 L265P is a marker highly characteristic of, but not restricted to, Waldenström's macroglobulinemia.

Leukemia 2013 Aug 28;27(8):1722-8. Epub 2013 Feb 28.

Department of Hematology, University Hospital of Salamanca, Salamanca, Spain.

We evaluated the MYD88 L265P mutation in Waldenström's macroglobulinemia (WM) and B-cell lymphoproliferative disorders by specific polymerase chain reaction (PCR) (sensitivity ∼10(-3)). No mutation was seen in normal donors, while it was present in 101/117 (86%) WM patients, 27/31 (87%) IgM monoclonal gammapathies of uncertain significance (MGUS), 3/14 (21%) splenic marginal zone lymphomas and 9/48 (19%) non-germinal center (GC) diffuse large B-cell lymphomas (DLBCLs). The mutation was absent in all 28 GC-DLBCLs, 13 DLBCLs not subclassified, 35 hairy cell leukemias, 39 chronic lymphocytic leukemias (16 with M-component), 25 IgA or IgG-MGUS, 24 multiple myeloma (3 with an IgM isotype), 6 amyloidosis, 9 lymphoplasmacytic lymphomas and 1 IgM-related neuropathy. Among WM and IgM-MGUS, MYD88 L265P mutation was associated with some differences in clinical and biological characteristics, although usually minor; wild-type MYD88 cases had smaller M-component (1.77 vs 2.72 g/dl, P=0.022), more lymphocytosis (24 vs 5%, P=0.006), higher lactate dehydrogenase level (371 vs 265 UI/L, P=0.002), atypical immunophenotype (CD23-CD27+ +FMC7+ +), less Immunoglobulin Heavy Chain Variable gene (IGHV) somatic hypermutation (57 vs 97%, P=0.012) and less IGHV3-23 gene selection (9 vs 27%, P=0.014). These small differences did not lead to different time to first therapy, response to treatment or progression-free or overall survival.

Download full-text PDF

Source
http://dx.doi.org/10.1038/leu.2013.62DOI Listing
August 2013
4 Reads

Publication Analysis

Top Keywords

myd88 l265p
12
waldenström's macroglobulinemia
8
l265p mutation
8
immunoglobulin heavy
4
leukemias chronic
4
chronic lymphocytic
4
cell leukemias
4
hairy cell
4
dlbcls subclassified
4
subclassified hairy
4
heavy chain
4
lymphocytic leukemias
4
leukemias m-component
4
igg-mgus multiple
4
cd23-cd27+ +fmc7+
4
multiple myeloma
4
iga igg-mgus
4
myd88
4
+fmc7+ immunoglobulin
4
m-component iga
4

References

(Supplied by CrossRef)

FD Groves et al.
Cancer 1998

LJ Herrinton et al.
Blood 1993

R Garcia-Sanz et al.
Br J Haematol 2001

KJ Phekoo et al.
Leukemia Res 2008

E Braggio et al.
Haematologica 2012

SP Treon et al.
N Engl J M 2012

VN Ngo et al.
Nature 2011

JG Lohr et al.
Proc Natl Acad Sci 2012

L Pasqualucci et al.
Nat Genet 2011

A Pham-Ledard et al.
J Invest Dermatol 2012

A Gonzalez-Aguilar et al.
Clin Cancer Res 2012

Similar Publications